United States Diabetes Drugs Market Report 2018

June 2018 | 106 pages | ID: UC2E5964DB8EN
QYResearch

Abstracts

In this report, the United States Diabetes Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Diabetes Drugs in these regions, from 2013 to 2025 (forecast).

United States Diabetes Drugs market competition by top manufacturers/players, with Diabetes Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi
• Novo Nordisk
• MSD
• Astrazeneca
• Takeda
• Novartis
• North China Pharmaceutical Group Corporation
• Huadong Medicine
• Dongbao Pharmaceutical Co.,LTD
• Hisun Pharmacy
• KELUN
• Ginwa
• Tianan Pharmaceutical
• Jumpcan Pharmacy
• Guangzhou Baiyun Mountain
• SHIJIAZHUANG YILING PHARMACEUTICAL CO.,LTD
• Wanbang Biopharmaceuticals
• Gan & Lee
• Taloph

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Sulphonylureas
• Biguanides
• Meglitinides
• Thiazolidinediones
• Alpha-glucosidase Inhibitors
• DPP-4 Inhibitors
• SGLT-2 Inhibitors

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Application 1
• Application 2

Contents

United States Diabetes Drugs Market Report 2018

1 DIABETES DRUGS OVERVIEW

1.1 Product Overview and Scope of Diabetes Drugs
1.2 Classification of Diabetes Drugs by Product Category
  1.2.1 United States Diabetes Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Diabetes Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Sulphonylureas
  1.2.4 Biguanides
  1.2.5 Meglitinides
  1.2.6 Thiazolidinediones
  1.2.7 Alpha-glucosidase Inhibitors
  1.2.8 DPP-4 Inhibitors
  1.2.9 SGLT-2 Inhibitors
1.3 United States Diabetes Drugs Market by Application/End Users
  1.3.1 United States Diabetes Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.1 Application
  1.3.2 Application
1.4 United States Diabetes Drugs Market by Region
  1.4.1 United States Diabetes Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Diabetes Drugs Status and Prospect (2013-2025)
  1.4.3 Southwest Diabetes Drugs Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Diabetes Drugs Status and Prospect (2013-2025)
  1.4.5 New England Diabetes Drugs Status and Prospect (2013-2025)
  1.4.6 The South Diabetes Drugs Status and Prospect (2013-2025)
  1.4.7 The Midwest Diabetes Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Diabetes Drugs (2013-2025)
  1.5.1 United States Diabetes Drugs Sales and Growth Rate (2013-2025)
  1.5.2 United States Diabetes Drugs Revenue and Growth Rate (2013-2025)

2 UNITED STATES DIABETES DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Diabetes Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Diabetes Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Diabetes Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Diabetes Drugs Market Competitive Situation and Trends
  2.4.1 United States Diabetes Drugs Market Concentration Rate
  2.4.2 United States Diabetes Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Diabetes Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DIABETES DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Diabetes Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Diabetes Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Diabetes Drugs Price by Region (2013-2018)

4 UNITED STATES DIABETES DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Diabetes Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Diabetes Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Diabetes Drugs Price by Type (2013-2018)
4.4 United States Diabetes Drugs Sales Growth Rate by Type (2013-2018)

5 UNITED STATES DIABETES DRUGS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Diabetes Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Diabetes Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES DIABETES DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Diabetes Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Novo Nordisk
  6.2.2 Diabetes Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novo Nordisk Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 MSD
  6.3.2 Diabetes Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 MSD Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Astrazeneca
  6.4.2 Diabetes Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Astrazeneca Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Takeda
  6.5.2 Diabetes Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Takeda Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.2 Diabetes Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 North China Pharmaceutical Group Corporation
  6.7.2 Diabetes Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 North China Pharmaceutical Group Corporation Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Huadong Medicine
  6.8.2 Diabetes Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Huadong Medicine Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Dongbao Pharmaceutical Co.,LTD
  6.9.2 Diabetes Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Dongbao Pharmaceutical Co.,LTD Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Hisun Pharmacy
  6.10.2 Diabetes Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Hisun Pharmacy Diabetes Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 KELUN
6.12 Ginwa
6.13 Tianan Pharmaceutical
6.14 Jumpcan Pharmacy
6.15 Guangzhou Baiyun Mountain
6.16 SHIJIAZHUANG YILING PHARMACEUTICAL CO.,LTD
6.17 Wanbang Biopharmaceuticals
6.18 Gan & Lee
6.19 Taloph

7 DIABETES DRUGS MANUFACTURING COST ANALYSIS

7.1 Diabetes Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Diabetes Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Diabetes Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Diabetes Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DIABETES DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Diabetes Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Diabetes Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Diabetes Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Diabetes Drugs Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Diabetes Drugs
Figure United States Diabetes Drugs Market Size (K Units) by Type (2013-2025)
Figure United States Diabetes Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Sulphonylureas Product Picture
Figure Biguanides Product Picture
Figure Meglitinides Product Picture
Figure Thiazolidinediones Product Picture
Figure Alpha-glucosidase Inhibitors Product Picture
Figure DPP-4 Inhibitors Product Picture
Figure SGLT-2 Inhibitors Product Picture
Figure United States Diabetes Drugs Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Diabetes Drugs by Application in 2017
Table Key Downstream Customer in Application
Table Key Downstream Customer in Application
Figure United States Diabetes Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Diabetes Drugs Sales (K Units) and Growth Rate (2013-2025)
Figure United States Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Diabetes Drugs Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Diabetes Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Diabetes Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Diabetes Drugs Sales Share by Players/Suppliers
Figure 2017 United States Diabetes Drugs Sales Share by Players/Suppliers
Figure United States Diabetes Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Diabetes Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Diabetes Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Diabetes Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Diabetes Drugs Revenue Share by Players/Suppliers
Table United States Market Diabetes Drugs Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Diabetes Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Diabetes Drugs Market Share of Top 3 Players/Suppliers
Figure United States Diabetes Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Diabetes Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Diabetes Drugs Product Category
Table United States Diabetes Drugs Sales (K Units) by Region (2013-2018)
Table United States Diabetes Drugs Sales Share by Region (2013-2018)
Figure United States Diabetes Drugs Sales Share by Region (2013-2018)
Figure United States Diabetes Drugs Sales Market Share by Region in 2017
Table United States Diabetes Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Diabetes Drugs Revenue Share by Region (2013-2018)
Figure United States Diabetes Drugs Revenue Market Share by Region (2013-2018)
Figure United States Diabetes Drugs Revenue Market Share by Region in 2017
Table United States Diabetes Drugs Price (USD/Unit) by Region (2013-2018)
Table United States Diabetes Drugs Sales (K Units) by Type (2013-2018)
Table United States Diabetes Drugs Sales Share by Type (2013-2018)
Figure United States Diabetes Drugs Sales Share by Type (2013-2018)
Figure United States Diabetes Drugs Sales Market Share by Type in 2017
Table United States Diabetes Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Diabetes Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Diabetes Drugs by Type (2013-2018)
Figure Revenue Market Share of Diabetes Drugs by Type in 2017
Table United States Diabetes Drugs Price (USD/Unit) by Types (2013-2018)
Figure United States Diabetes Drugs Sales Growth Rate by Type (2013-2018)
Table United States Diabetes Drugs Sales (K Units) by Application (2013-2018)
Table United States Diabetes Drugs Sales Market Share by Application (2013-2018)
Figure United States Diabetes Drugs Sales Market Share by Application (2013-2018)
Figure United States Diabetes Drugs Sales Market Share by Application in 2017
Table United States Diabetes Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Diabetes Drugs Sales Growth Rate by Application (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Diabetes Drugs Sales Growth Rate (2013-2018)
Figure Sanofi Diabetes Drugs Sales Market Share in United States (2013-2018)
Figure Sanofi Diabetes Drugs Revenue Market Share in United States (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Diabetes Drugs Sales Growth Rate (2013-2018)
Figure Novo Nordisk Diabetes Drugs Sales Market Share in United States (2013-2018)
Figure Novo Nordisk Diabetes Drugs Revenue Market Share in United States (2013-2018)
Table MSD Basic Information List
Table MSD Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure MSD Diabetes Drugs Sales Growth Rate (2013-2018)
Figure MSD Diabetes Drugs Sales Market Share in United States (2013-2018)
Figure MSD Diabetes Drugs Revenue Market Share in United States (2013-2018)
Table Astrazeneca Basic Information List
Table Astrazeneca Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Astrazeneca Diabetes Drugs Sales Growth Rate (2013-2018)
Figure Astrazeneca Diabetes Drugs Sales Market Share in United States (2013-2018)
Figure Astrazeneca Diabetes Drugs Revenue Market Share in United States (2013-2018)
Table Takeda Basic Information List
Table Takeda Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Diabetes Drugs Sales Growth Rate (2013-2018)
Figure Takeda Diabetes Drugs Sales Market Share in United States (2013-2018)
Figure Takeda Diabetes Drugs Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Diabetes Drugs Sales Growth Rate (2013-2018)
Figure Novartis Diabetes Drugs Sales Market Share in United States (2013-2018)
Figure Novartis Diabetes Drugs Revenue Market Share in United States (2013-2018)
Table North China Pharmaceutical Group Corporation Basic Information List
Table North China Pharmaceutical Group Corporation Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure North China Pharmaceutical Group Corporation Diabetes Drugs Sales Growth Rate (2013-2018)
Figure North China Pharmaceutical Group Corporation Diabetes Drugs Sales Market Share in United States (2013-2018)
Figure North China Pharmaceutical Group Corporation Diabetes Drugs Revenue Market Share in United States (2013-2018)
Table Huadong Medicine Basic Information List
Table Huadong Medicine Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Huadong Medicine Diabetes Drugs Sales Growth Rate (2013-2018)
Figure Huadong Medicine Diabetes Drugs Sales Market Share in United States (2013-2018)
Figure Huadong Medicine Diabetes Drugs Revenue Market Share in United States (2013-2018)
Table Dongbao Pharmaceutical Co.,LTD Basic Information List
Table Dongbao Pharmaceutical Co.,LTD Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Dongbao Pharmaceutical Co.,LTD Diabetes Drugs Sales Growth Rate (2013-2018)
Figure Dongbao Pharmaceutical Co.,LTD Diabetes Drugs Sales Market Share in United States (2013-2018)
Figure Dongbao Pharmaceutical Co.,LTD Diabetes Drugs Revenue Market Share in United States (2013-2018)
Table Hisun Pharmacy Basic Information List
Table Hisun Pharmacy Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hisun Pharmacy Diabetes Drugs Sales Growth Rate (2013-2018)
Figure Hisun Pharmacy Diabetes Drugs Sales Market Share in United States (2013-2018)
Figure Hisun Pharmacy Diabetes Drugs Revenue Market Share in United States (2013-2018)
Table KELUN Basic Information List
Table Ginwa Basic Information List
Table Tianan Pharmaceutical Basic Information List
Table Jumpcan Pharmacy Basic Information List
Table Guangzhou Baiyun Mountain Basic Information List
Table SHIJIAZHUANG YILING PHARMACEUTICAL CO.,LTD Basic Information List
Table Wanbang Biopharmaceuticals Basic Information List
Table Gan & Lee Basic Information List
Table Taloph Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Diabetes Drugs
Figure Manufacturing Process Analysis of Diabetes Drugs
Figure Diabetes Drugs Industrial Chain Analysis
Table Raw Materials Sources of Diabetes Drugs Major Players/Suppliers in 2017
Table Major Buyers of Diabetes Drugs
Table Distributors/Traders List
Figure United States Diabetes Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Diabetes Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Diabetes Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Diabetes Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Diabetes Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Diabetes Drugs Sales Volume (K Units) Forecast by Type in 2025
Table United States Diabetes Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Diabetes Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Diabetes Drugs Sales Volume (K Units) Forecast by Application in 2025
Table United States Diabetes Drugs Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Diabetes Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Diabetes Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Diabetes Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources